









Markets
/
Stocks
/
nasdaq-icu
/

SeaStar Medical Holding Corp

ICU

2.480USD

+0.070+2.90%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

8.46MMarket Cap

LossP/E TTM



SeaStar Medical Holding Corp

2.480

+0.070+2.90%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of SeaStar Medical Holding Corp

Currency: USD Updated: 2026-02-06

Key Insights

SeaStar Medical Holding Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 111 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 11.00.In the medium term, the stock price is expected to trend down.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

SeaStar Medical Holding Corp's Score

Industry at a Glance

Industry Ranking

111 / 205

Overall Ranking

291 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

SeaStar Medical Holding Corp Highlights

StrengthsRisks

SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).

Growing

The company is in a growing phase, with the latest annual income totaling USD 135.00K.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 135.00K.

Overvalued

The company’s latest PE is -0.22, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 111.65K shares, decreasing 21.85% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 37.74K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.96.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

11.000

Target Price

+356.43%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of SeaStar Medical Holding Corp is 7.51, ranking 78 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 183.00K, representing a year-over-year increase of 169.12%, while its net profit experienced a year-over-year increase of 22.47%.

Score

Industry at a Glance

Previous score

7.51

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.02

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

3.01

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.18

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.36

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

SeaStar Medical Holding Corp's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of SeaStar Medical Holding Corp is 7.09, ranking 127 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.22, which is -52.51% below the recent high of -0.10 and -2873.54% above the recent low of -6.51.

Score

Industry at a Glance

Previous score

7.09

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 111/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of SeaStar Medical Holding Corp is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 1.00, with a high of 1.00 and a low of 1.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

11.000

Target Price

+356.43%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

SeaStar Medical Holding Corp

ICU

Stryker Corp

SYK

Abbott Laboratories

ABT

Medtronic PLC

MDT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of SeaStar Medical Holding Corp is 5.27, ranking 181 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 2.89 and the support level at 2.15, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.16

Change

0.11

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(5)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.065

Neutral

RSI(14)

47.354

Neutral

STOCH(KDJ)(9,3,3)

46.026

Neutral

ATR(14)

0.202

Low Volatility

CCI(14)

3.997

Neutral

Williams %R

51.122

Neutral

TRIX(12,20)

-0.375

Sell

StochRSI(14)

49.922

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

2.486

Sell

MA10

2.448

Buy

MA20

2.476

Buy

MA50

2.743

Sell

MA100

3.543

Sell

MA200

2.231

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of SeaStar Medical Holding Corp is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 3.10%, representing a quarter-over-quarter increase of 24.65%. The largest institutional shareholder is The Vanguard, holding a total of 37.74K shares, representing 1.05% of shares outstanding, with 68.56% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

37.74K

+556.31%

Geode Capital Management, L.L.C.

25.89K

+276.17%

Millennium Management LLC

17.97K

Neuman (John)

8.27K

Trinity Financial Advisors LLC

5.00K

+233.33%

Schlorff (Eric)

5.52K

XTX Markets LLC

4.86K

-20.37%

Van Heel (Kenneth J.)

4.54K

+0.71%

Chung (Kevin)

3.32K

Dynamic Wealth Advisors

2.93K

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of SeaStar Medical Holding Corp is 1.17, ranking 196 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is -0.99. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.